Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (17)

2023

  1. Promising biomedical subcutaneous delivery system in opioid disaccustom process: In vitro/in vivo evaluation of naloxone microparticles on antagonist effect of morphine

    International Journal of Pharmaceutics, Vol. 635

2019

  1. Investigation on the Existence of Sex-By-Formulation Interaction in Bioequivalence Trials

    Clinical Pharmacology and Therapeutics, Vol. 106, Núm. 5, pp. 1099-1112

2017

  1. Novel technologies for the delivery of ocular therapeutics in glaucoma

    Journal of Drug Delivery Science and Technology, Vol. 42, pp. 181-192

  2. Targeting Schlemm’s Canal in the Medical Therapy of Glaucoma: Current and Future Considerations

    Advances in Therapy, Vol. 34, Núm. 5, pp. 1049-1069

2015

  1. Critical attributes of formulation and of elaboration process of PLGA-protein microparticles

    International Journal of Pharmaceutics, Vol. 480, Núm. 1-2, pp. 27-36

  2. Overcoming glucocorticoid resistances and improving antitumor therapies: Lipid and polymers carriers

    Pharmaceutical Research, Vol. 32, Núm. 3, pp. 968-985

2012

  1. Differences in lercanidipine systemic exposure when administered according to labelling: In fasting state and 15 minutes before food intake

    European Journal of Clinical Pharmacology, Vol. 68, Núm. 7, pp. 1043-1047

2011

  1. In vitro and in vivo evaluation of a folate-targeted copolymeric submicrohydrogel based on N-isopropylacrylamide as 5-fluorouracil delivery system

    Polymers, Vol. 3, Núm. 3, pp. 1107-1125

2008

  1. Tape stripping on a human nail: Quantification of removal

    Skin Research and Technology, Vol. 14, Núm. 4, pp. 472-477

2007

  1. The use of an excreted superoxide dismutase in an ELISA and Western blotting for the diagnosis of Leishmania (Leishmania) infantum naturally infected dogs

    Parasitology Research, Vol. 101, Núm. 3, pp. 801-808

2005

  1. Biodegradable additives modulate ganciclovir release rate from PLGA microspheres destined to intraocular administration

    Letters in Drug Design and Discovery, Vol. 2, Núm. 2, pp. 148-149

1991

  1. Comparative pharmacokinetics of two oral bezafibrate preparations.

    European journal of drug metabolism and pharmacokinetics, Vol. Spec No 3, pp. 261-267

  2. Dissolution kinetics of bezafibrate in two solid forms for oral administration.

    European journal of drug metabolism and pharmacokinetics, Vol. Spec No 3, pp. 371-378

  3. In vitro evaluation of the dissolution rate of crystalline suspensions destined to intramuscular administration.

    European journal of drug metabolism and pharmacokinetics, Vol. Spec No 3, pp. 379-384

  4. Pharmacokinetic study of etodolac after rectal administration; "in vitro" release kinetics.

    European journal of drug metabolism and pharmacokinetics, Vol. Spec No 3, pp. 389-396

  5. Solid dispersions of oxodipine/PEG 6000 characterization and dissolution study

    S.T.P. Pharma Sciences, Vol. 1, Núm. 2, pp. 125-129

1980

  1. INFLUENCIA DE pH Y AGENTES SOLUBILIZANTES EN LA ESTABILIDAD DEL FENOBARBITAL

    Bollettino Chimico Farmaceutico, Vol. 119, Núm. 7, pp. 405-416